Amedeo Smart

Free Medical Literature Service


 

Amedeo

Kidney Transplantation

  Free Subscription

Articles published in
Br J Clin Pharmacol
    June 2022
  1. ZWART TC, Metscher E, van der Boog PJM, Swen JJ, et al
    Volumetric microsampling for simultaneous remote immunosuppressant and kidney function monitoring in outpatient kidney transplant recipients.
    Br J Clin Pharmacol. 2022 Jun 7. doi: 10.1111/bcp.15433.
    >> Share

    May 2022
  2. ZHOU Y, Li Y, Xie X, Song L, et al
    Higher Incidence of Neurotoxicity and Skin Hyperpigmentation in Renal Transplant Patients Treated With Polymyxin B.
    Br J Clin Pharmacol. 2022 May 4. doi: 10.1111/bcp.15384.
    >> Share

    January 2022
  3. LE TILLY O, Gatault P, Baron C, Bejan-Angoulvant T, et al
    Is CD25 blockade optimal in kidney transplant patients treated with basiliximab? A target-mediated drug disposition (TMDD) model.
    Br J Clin Pharmacol. 2022 Jan 18. doi: 10.1111/bcp.15235.
    >> Share

    December 2021
  4. DESTERE A, Gandonniere CS, Asberg A, Loustaud-Ratti V, et al
    A single Bayesian estimator for iohexol clearance estimation in ICU, liver failure and renal transplant patients.
    Br J Clin Pharmacol. 2021 Dec 23. doi: 10.1111/bcp.15197.
    >> Share

    October 2021
  5. SOMMERER C, Brunet M, Budde K, Millan O, et al
    Monitoring of gene expression in tacrolimus-treated de novo renal allograft recipients facilitates individualized immunosuppression: Results of the IMAGEN study.
    Br J Clin Pharmacol. 2021;87:3851-3862.
    >> Share

    April 2021
  6. YIN S, Wang X, Huang Z, Fan Y, et al
    Tacrolimus Variability Score Outperforms Coefficient of Variation in Predicting Clinical Outcomes of Living Kidney Transplantation.
    Br J Clin Pharmacol. 2021 Apr 25. doi: 10.1111/bcp.14876.
    >> Share

  7. RONG Y, Jun H, Kiang TKL
    Population pharmacokinetics of mycophenolic acid in paediatric patients.
    Br J Clin Pharmacol. 2021;87:1730-1757.
    >> Share

    March 2021
  8. SALLUSTIO BC, Noll BD, Hu R, Barratt DT, et al
    Tacrolimus dose, blood concentrations and acute nephrotoxicity, but not CYP3A5/ABCB1 genetics, are associated with allograft tacrolimus concentrations in renal transplant recipients.
    Br J Clin Pharmacol. 2021 Mar 1. doi: 10.1111/bcp.14806.
    >> Share

    December 2020
  9. JONES TE
    Problems with paper entitled The impact of tacrolimus exposure on extrarenal adverse effects in adult transplant recipients.
    Br J Clin Pharmacol. 2020;86:2536-2537.
    >> Share

  10. ROBERTSEN I, Woillard JB, Asberg A
    Why dose adjust systemic exposure when looking for associations with adverse events in tacrolimus-treated transplant recipients?
    Br J Clin Pharmacol. 2020;86:2535.
    >> Share

    October 2020
  11. FRANCKE MI, Hesselink DA, Li Y, Koch BCP, et al
    Monitoring the Tacrolimus Concentration in peripheral bLood mononuclear cells of Kidney Transplant Recipients.
    Br J Clin Pharmacol. 2020 Oct 6. doi: 10.1111/bcp.14585.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016